• Accelerating TB vaccine Research & Development through partnership
  • TBVI TBVI TBVI
    • Home
    • About us
      • TBVI at a glance
      • Mission
      • Organisation
        • Governance Board
        • Advisory Committee
        • Steering Committee
        • Operational Office
        • Product and Clinical Development Team
        • Portfolio Management Committee
      • TBVI consortium
      • Key achievements and impact
      • Financials
      • Policies
    • What we do
      • Pipeline of vaccines
      • Research & Development
      • Services
    • How we work
      • Business model
      • Partnership
    • For partners
      • For researchers and vaccine developers
        • Partners pages
        • Access to services
      • MTBVAC in Newborns
        • Coordinator and partners
        • News and Publications
        • Communication tools
      • MTBVACN3
        • Work packages
        • Governance
        • The consortium and its partners
        • Publications and news
        • Acknowledgement
      • TBVAC2020
        • Word from the chair
        • TBVAC2020 project overview and achievements
        • TBVAC2020 project members
        • TBVAC2020 scientific publications
        • TBVAC2020 other publications
      • For funders
        • TBVI R&D priorities and funding opportunities
        • TBVI service provision and funding opportunities
        • Why invest in TBVI
    • News
    • Contact us:

    Archives

    Monthly Archive for: "May, 2021"
    Home / 2021 / May
      0
    By Cora Agterdenbosch
    In Uncategorized Posted May 27, 2021

    Virtual Global Forum on TB Vaccines Summary and Presentations

    The  Virtual Global Forum on TB Vaccines took place from 20 – 22 April 2021, bringing together more than 365 researchers, product developers, policy makers, advocates, and other stakeholders from [...]

    Read More
      0
    By Cora Agterdenbosch
    In Uncategorized Posted May 20, 2021

    Working together on TB: Next Steps

    The FII Institute (Future Investment Initiative Institute) is a next generation global foundation working to ensure the world’s brightest ideas find their way to build, scale and create positive [...]

    Read More
      0
    By Marit Holleman
    In Uncategorized Posted May 4, 2021

    New support tools for TB vaccine R&D published

    TBVI has coordinated the development of several new tools to support future TB vaccine clinical trials. Experts in the field together with researchers from the ongoing EDCTP-funded TB vaccine [...]

    Read More
    Load More
    Menu
    • Home
    • About us
    • What we do
    • How we work
    • For researchers and vaccine developers
    • For funders
    • Pipeline of vaccines
    • News
    TuBerculosis Vaccine Initiative (TBVI)

    Runderweg 6
    8219 PK Lelystad
    The Netherlands
    Email: info@tbvi.eu
    Phone: +31 320 277 550

    © 2015 TuBerculosis Vaccine Initiative (TBVI) | ALL RIGHTS RESERVED | Disclaimer | Sitemap | Door Internetbureau Redkiwi

    Start typing and press Enter to search

    Cookies

    This website uses cookies that help the website function

    OK No